Fatal outcome of a disseminated dual infection with drug-resistant Mycoplasma hominis and Ureaplasma parvum originating from a septic arthritis in an immunocompromised patient

International Journal of Infectious Diseases

Volumn 14, Issue SUPPL. 3, 2010, Pages

  MacKenzie, Colin R ^a   Nischik, Nicole ^a   Kram, Rainer ^a   Krauspe, Rüdiger ^a   Jäger, Marcus ^a   Henrich, Birgit ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Antibiotic resistance; Disseminated infection; Joint infection; Mycoplasma hominis; Ureaplasma parvum

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; LINEZOLID; MEROPENEM; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; RITUXIMAB;

ADULT; ANAMNESIS; ARTHROSCOPY; ARTICLE; BACTERIAL ARTHRITIS; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM ISOLATE; CLINICAL ARTICLE; HISTOPATHOLOGY; HOSPITAL INFECTION; HUMAN; HUMAN TISSUE; IMMUNOCOMPROMISED PATIENT; JOINT BIOPSY; LABORATORY TEST; MALE; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA HOMINIS INFECTION; STAPHYLOCOCCUS INFECTION; UREAPLASMA PARVUM INFECTION;

ARTHRITIS, INFECTIOUS; ARTHROPLASTY, REPLACEMENT, HIP; CROSS INFECTION; FATAL OUTCOME; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOPLASMA HOMINIS; MYCOPLASMA INFECTIONS; UREAPLASMA INFECTIONS;

EID: 77957348606     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2010.02.2253     Document Type: Article

References (12)

1. Pereyre S., Renaudin H., Charron A., Bébéar C., Bébéar C.M. Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin. J Antimicrob Chemother 2006, 57:753-756.
2. Fenollar F., Casalta J.P., Lepidi H., Piquet P., Raoult D. Mycoplasma infections of aneurysms or vascular grafts. Clin Infect Dis 1999, 28:694-695.
3. Bébéar C.M., Renaudin H., Charron A., Clerc M., Pereyre S., Bébéar C. DNA gyrase and topoisomerase IV mutations in clinical isolates of Ureaplasma spp. and Mycoplasma hominis resistant to fluoroquinolones. Antimicrob Agents Chemother 2003, 47:3323-3325.
4. Kenny G.E., Cartwright F.D. Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones. Antimicrob Agents Chemother 2001, 45:2604-2608.
5. Henrich B., Feldmann R.C., Hadding U. Cytoadhesins of Mycoplasma hominis. Infect Immun 1993, 61:2945-2951.
6. Waites K.B., Canupp K.C. Evaluation of BacT/ALERT system for detection of Mycoplasma hominis in simulated blood cultures. J Clin Microbiol 2001, 39:4328-4331.
7. Fenollar F., Gauduchon V., Casalta J.P., Lepidi H., Vandenesch F., Raoult D. Mycoplasma endocarditis: two case reports and a review. Clin Infect Dis 2004, 38:e21-e24.
8. Bakker-de Wekker P., Alfieri O., Vermeulen F., Knaepen P., De Geest R., Defauw J. Surgical treatment of infected pseudoaneurysms after replacement of the ascending aorta. J Thorac Cardiovasc Surg 1984, 88:447-451.
9. Levi N., Prag J., Skov Jensen J., Just S., Schroeder T.V., Lorentzen J.E. Aortic graft infection with Mycoplasma (Ureaplasma urealyticum). Eur J Vasc Endovasc Surg 1995, 10:374-375.
10. García C., Ugalde E., Monteagudo I., Saez A., Agüero J., Martinez-Martinez L., Miñambres E. Isolation of Mycoplasma hominis in critically ill patients with pulmonary infections: clinical and microbiological analysis in an intensive care unit. Intensive Care Med 2007, 33:143-147.
11. García-de-la-Fuente C., Miñambres E., Ugalde E., Sáez A., Martinez-Martinez L., Fariñas M.C. Post-operative mediastinitis, pleuritis and pericarditis due to Mycoplasma hominis and Ureaplasma urealyticum with a fatal outcome. J Med Microbiol 2008, 57(Pt 5):656-657.
12. Nylander N., Tan M., Newcombe D.S. Successful management of Mycoplasma hominis septic arthritis involving a cementless prosthesis. Am J Med 1989, 87:348-352.